Harrison & Co Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$1.22M Sell
3,333
-477
-13% -$169K 1.18% 22
2022
Q3
$1.23M Sell
3,810
-633
-14% -$201K 1.31% 20
2022
Q2
$1.44M Sell
4,443
-158
-3% -$47.4K 1.37% 17
2022
Q1
$1.32M Sell
4,601
-119
-3% -$30.6K 1.16% 21
2021
Q4
$1.3M Buy
+4,720
New +$1.2M 1.1% 22

Other funds holding LLY

Harrison & Co Wealth Management's LLY Position: Q4 2022 in Review

Harrison & Co Wealth Management reduced its Eli Lilly (LLY) stake by 13% in Q4 2022, selling an estimated $169K and leaving 3,333 shares worth $1.22M. The position accounts for 1.18% of the portfolio, ranked #22.

Harrison & Co Wealth Management first reported a position in LLY in Q4 2021 and has held it in 5 quarters since. The position peaked at $1.44M in Q2 2022. 2,671 funds tracked by Wall St. Rank hold LLY as of Q4 2022.

  • Harrison & Co Wealth Management held 3,333 shares of Eli Lilly worth $1.22M as of Q4 2022.
  • Harrison & Co Wealth Management sold 477 Eli Lilly shares in Q4 2022, an estimated $169K.
  • Eli Lilly made up 1.18% of Harrison & Co Wealth Management's portfolio in Q4 2022, its #22 holding.
  • Harrison & Co Wealth Management first reported a position in Eli Lilly in Q4 2021 and has held it in 5 quarters since.
  • Harrison & Co Wealth Management's Eli Lilly position peaked at $1.44M in Q2 2022.
  • 2,671 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2022.

Based on Harrison & Co Wealth Management's 13F filing for Q4 2022, filed 17 Jan 2023.